San Francisco’s board of supervisors recently approved an ordinance for a full drug take-back program to combat prescription drug abuse and contaminants in drinking water, which would make it the first major city to implement ...

Last month a Nevada State Senator introduced a bill that would fund a heroin-assisted treatment pilot program—the first attempt of its kind to introduce this kind of program at the state and federal levels.    ...

Since researchers have cited weak marijuana provided by the government and a lack of cannabidiol varieties, the National Institute on Drug Abuse (NIDA) has realized that researchers need access to the varieties of marijuana that ...

A new study found that a significant amount of doctors are not using the prescription drug monitoring databases provided to them to stop patients “shopping” for medication.    The Johns Hopkins University researchers discovered that ...

The Centers for Disease Control and Prevention (CDC) recently released a new report that shows a high rise in deaths resulting from heroin overdoses in the US.    The report showed that rates of the ...

A NIDA-funded clinical trial recently revealed that a combination of outpatient Suboxone detoxification followed by postdetox naltrexone therapy has good outcomes for patients with opioid dependence.    The study was a double-blind, randomized clinical trial ...

A new study published in the PNAS journal revealed that oxytocin, the hormone associated with feelings of love, could lessen the effects of alcohol.    The study was conducted by researchers at the University of ...

The ADHD drug called Vyvanse has recently been approved by the FDA to treat binge-eating disorder, becoming the first drug to be approved for this condition.    Clinical studies using 724 people found that participants ...

A new study published in the New England Journal of Medicine found that smoking is linked to five more diseases, which adds approximately sixty thousand deaths per year to the previous numbers.    The study ...

For the first time in many decades, the federal government will be reconsidering marijuana’s classification as a Schedule I drug.    Towards the end of last year, Judge Kimberly J. Mueller “agreed to hold a ...